Comparison of Contrast Induced Nephropathy in Diabetics and Non-Diabetics after Percutaneous Coronary Intervention in Previously Normal Renal Functions
Aim: To compare the incidence and severity of contrast-induced nephropathy (CIN) in patients who underwent percutaneous coronary intervention at tertiary care hospital of Pakistan.
Study design: Prospective analytic cross-sectional study.
Place and duration of study: Department of Cardiology of a Tertiary Cardiac Care Center of Pakistan from 1st April 2022 to 30th September 2022.
Methodology: Two hundred and fifty patients of coronary artery disease older than 18 years irrespective of gender were enrolled using non-probability consecutive sampling technique. The patients were divided into two groups; diabetic and non-diabetic, who received a contrast medium during the procedure.
Results: Thirty seven (14.66%) patients were diagnosed with CIN after percutaneous coronary intervention. Patients with diabetes 25(69%) were more prone to develop CIN compared with non-diabetic patients 12(31%). Also, patients with diabetes have significantly high levels of post procedure creatinine levels compared with the non-diabetic patients.
Practical Implication: it is cleared from the body by glomerular filtration. The mechanism of CIN is dependent on the medullary ischemia, oxidative stress and tubular cell toxicity.
Conclusion: Contrast-induced nephropathy is a common complication following percutaneous coronary intervention and is more prevalent in diabetic patients. However, none of the patients require hemodialysis.
Keywords: Contrast-induced nephropathy, Diabetic, Non-diabetic, Percutaneous coronary intervention, Renal function